LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.95 | 84.90 | 1188 | 4952 | 0.2399 | 0.5680 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.95 | 84.90 | 64 | 4952 | 0.0129 | -0.0470 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.95 | 84.90 | 1172 | 4952 | 0.2367 | 0.5644 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.65 | 84.90 | 118 | 5328 | 0.0221 | 0.0567 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.65 | 84.90 | 1221 | 5328 | 0.2291 | 0.5627 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.65 | 84.90 | 59 | 5328 | 0.0111 | -0.0591 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.65 | 84.90 | 1169 | 5328 | 0.2194 | 0.5514 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.36 | 84.90 | 137 | 5651 | 0.0242 | 0.0822 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.36 | 84.90 | 1231 | 5651 | 0.2178 | 0.5551 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.36 | 84.90 | 78 | 5651 | 0.0138 | -0.0139 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.36 | 84.90 | 1207 | 5651 | 0.2136 | 0.5500 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 52.06 | 84.90 | 135 | 5990 | 0.0225 | 0.0785 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 52.06 | 84.90 | 1243 | 5990 | 0.2075 | 0.5481 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 52.06 | 84.90 | 80 | 5990 | 0.0134 | -0.0096 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 52.06 | 84.90 | 1242 | 5990 | 0.2073 | 0.5479 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.77 | 84.90 | 148 | 6252 | 0.0237 | 0.0937 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.77 | 84.90 | 1265 | 6252 | 0.2023 | 0.5458 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.77 | 84.90 | 79 | 6252 | 0.0126 | -0.0115 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.77 | 84.90 | 1274 | 6252 | 0.2038 | 0.5475 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.48 | 84.90 | 154 | 6567 | 0.0234 | 0.0996 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.48 | 84.90 | 1292 | 6567 | 0.1967 | 0.5434 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.48 | 84.90 | 79 | 6567 | 0.0120 | -0.0114 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.48 | 84.90 | 1273 | 6567 | 0.1938 | 0.5397 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 57.18 | 84.90 | 166 | 6963 | 0.0238 | 0.1112 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 57.18 | 84.90 | 1322 | 6963 | 0.1899 | 0.5401 | MN20160318_Q02 | C15 |